Acute toxic effects of ‘Ecstasy’ (MDMA) and related compounds: overview of pathophysiology and clinical management

2006/04/05 by Andrew P. Hall, A.P. Hall, John A. Henry +1 · 8 citations
Medicine · Pharmacology, Toxicology and Pharmaceutics · Psychology · #Cannabis and Cannabinoid Research #Forensic Toxicology and Drug Analysis #Psychedelics and Drug Studies

paper · doi:10.1093/bja/ael078

openalex publication_date 2006/04/05 · crossref created 2006/04/05 · crossref issued 2006/06/01 · crossref published 2006/06/01 · crossref published-print 2006/06/01 · crossref deposited 2023/05/06 · openalex created_date 2025/10/10 · crossref indexed 2026/07/04 · openalex updated_date 2026/07/22

Citations

• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

Cited by

• The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), methamphetamine and d-amphetamine
• Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine After Controlled Oral Administration to Young Adults
• Nephrotoxic Effects of Common and Emerging Drugs of Abuse
• Can MDMA Play a Role in the Treatment of Substance Abuse?
• Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans
• How MDMA's Pharmacology and Pharmacokinetics Drive Desired Effects and Harms
• Methylenedioxymethamphetamine (‘Ecstasy’)‐induced immunosuppression: a cause for concern?
• MDMA [wikipedia]